Cargando…
A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancer
Passive antibody therapy for cancer is an effective but costly treatment modality. Induction of therapeutically potent anticancer antibodies by active vaccination is an attractive alternative but has proven challenging in cancer due to tolerogenic pressure in patients. Here, we used the clinically r...
Autores principales: | Chotprakaikiat, Warayut, Allen, Alex, Bui-Minh, Duc, Harden, Elena, Jobsri, Jantipa, Cavallo, Federica, Gleba, Yuri, Stevenson, Freda K., Ottensmeier, Christian, Klimyuk, Victor, Savelyeva, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938312/ https://www.ncbi.nlm.nih.gov/pubmed/27471642 http://dx.doi.org/10.1080/2162402X.2016.1166323 |
Ejemplares similares
-
Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody
por: Jobsri, Jantipa, et al.
Publicado: (2015) -
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
por: Allen, Alex, et al.
Publicado: (2018) -
Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma
por: Tusé, Daniel, et al.
Publicado: (2015) -
CD28 Aptamers as Powerful Immune Response Modulators
por: Pastor, Fernando, et al.
Publicado: (2013) -
Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth
por: Komarova, Tatiana V., et al.
Publicado: (2011)